COVID-19 Impact on Global Gefitinib Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Gefitinib Product Introduction
• 1.2 Market Segments
• 1.3 Key Gefitinib Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Gefitinib Market Size Growth Rate by Type
  • 1.4.2 10 Tables/Box
  • 1.4.3 30 Tables/Box
  • 1.4.4 90 Tables/Box
• 1.5 Market by Application
  • 1.5.1 Global Gefitinib Market Size Growth Rate by Application
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Drug Center
  • 1.5.5 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Gefitinib Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Gefitinib Industry
    • 1.6.1.1 Gefitinib Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Gefitinib Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Gefitinib Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Gefitinib Market Size Estimates and Forecasts
  • 2.1.1 Global Gefitinib Revenue 2015-2026
  • 2.1.2 Global Gefitinib Sales 2015-2026
• 2.2 Gefitinib Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Gefitinib Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Gefitinib Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Gefitinib Competitor Landscape by Players

• 3.1 Gefitinib Sales by Manufacturers
  • 3.1.1 Gefitinib Sales by Manufacturers (2015-2020)
  • 3.1.2 Gefitinib Sales Market Share by Manufacturers (2015-2020)
• 3.2 Gefitinib Revenue by Manufacturers
  • 3.2.1 Gefitinib Revenue by Manufacturers (2015-2020)
  • 3.2.2 Gefitinib Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Gefitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Gefitinib Revenue in 2019
  • 3.2.5 Global Gefitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Gefitinib Price by Manufacturers
• 3.4 Gefitinib Manufacturing Base Distribution, Product Types
  • 3.4.1 Gefitinib Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Gefitinib Product Type
  • 3.4.3 Date of International Manufacturers Enter into Gefitinib Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Gefitinib Market Size by Type (2015-2020)
  • 4.1.1 Global Gefitinib Sales by Type (2015-2020)
  • 4.1.2 Global Gefitinib Revenue by Type (2015-2020)
  • 4.1.3 Gefitinib Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Gefitinib Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Gefitinib Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Gefitinib Revenue Forecast by Type (2021-2026)
  • 4.2.3 Gefitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Gefitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Gefitinib Market Size by Application (2015-2020)
  • 5.1.1 Global Gefitinib Sales by Application (2015-2020)
  • 5.1.2 Global Gefitinib Revenue by Application (2015-2020)
  • 5.1.3 Gefitinib Price by Application (2015-2020)
• 5.2 Gefitinib Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Gefitinib Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Gefitinib Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Gefitinib Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Gefitinib by Country
  • 6.1.1 North America Gefitinib Sales by Country
  • 6.1.2 North America Gefitinib Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Gefitinib Market Facts & Figures by Type
• 6.3 North America Gefitinib Market Facts & Figures by Application

7 Europe

• 7.1 Europe Gefitinib by Country
  • 7.1.1 Europe Gefitinib Sales by Country
  • 7.1.2 Europe Gefitinib Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Gefitinib Market Facts & Figures by Type
• 7.3 Europe Gefitinib Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Gefitinib by Region
  • 8.1.1 Asia Pacific Gefitinib Sales by Region
  • 8.1.2 Asia Pacific Gefitinib Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Gefitinib Market Facts & Figures by Type
• 8.3 Asia Pacific Gefitinib Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Gefitinib by Country
  • 9.1.1 Latin America Gefitinib Sales by Country
  • 9.1.2 Latin America Gefitinib Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Gefitinib Market Facts & Figures by Type
• 9.3 Central & South America Gefitinib Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Gefitinib by Country
  • 10.1.1 Middle East and Africa Gefitinib Sales by Country
  • 10.1.2 Middle East and Africa Gefitinib Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Gefitinib Market Facts & Figures by Type
• 10.3 Middle East and Africa Gefitinib Market Facts & Figures by Application

11 Company Profiles

• 11.1 AstraZeneca
  • 11.1.1 AstraZeneca Corporation Information
  • 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
  • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 AstraZeneca Gefitinib Products Offered
  • 11.1.5 AstraZeneca Recent Development
• 11.2 Qilu Pharmaceutical
  • 11.2.1 Qilu Pharmaceutical Corporation Information
  • 11.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
  • 11.2.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Qilu Pharmaceutical Gefitinib Products Offered
  • 11.2.5 Qilu Pharmaceutical Recent Development
• 11.3 Natco Pharma
  • 11.3.1 Natco Pharma Corporation Information
  • 11.3.2 Natco Pharma Description, Business Overview and Total Revenue
  • 11.3.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Natco Pharma Gefitinib Products Offered
  • 11.3.5 Natco Pharma Recent Development
• 11.4 Celon Laboratories
  • 11.4.1 Celon Laboratories Corporation Information
  • 11.4.2 Celon Laboratories Description, Business Overview and Total Revenue
  • 11.4.3 Celon Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Celon Laboratories Gefitinib Products Offered
  • 11.4.5 Celon Laboratories Recent Development
• 11.5 Hetero Drugs
  • 11.5.1 Hetero Drugs Corporation Information
  • 11.5.2 Hetero Drugs Description, Business Overview and Total Revenue
  • 11.5.3 Hetero Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Hetero Drugs Gefitinib Products Offered
  • 11.5.5 Hetero Drugs Recent Development
• 11.6 Dr Reddy's Laboratories
  • 11.6.1 Dr Reddy's Laboratories Corporation Information
  • 11.6.2 Dr Reddy's Laboratories Description, Business Overview and Total Revenue
  • 11.6.3 Dr Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Dr Reddy's Laboratories Gefitinib Products Offered
  • 11.6.5 Dr Reddy's Laboratories Recent Development
• 11.7 Zuventus Healthcare
  • 11.7.1 Zuventus Healthcare Corporation Information
  • 11.7.2 Zuventus Healthcare Description, Business Overview and Total Revenue
  • 11.7.3 Zuventus Healthcare Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Zuventus Healthcare Gefitinib Products Offered
  • 11.7.5 Zuventus Healthcare Recent Development
• 11.8 United Biotech
  • 11.8.1 United Biotech Corporation Information
  • 11.8.2 United Biotech Description, Business Overview and Total Revenue
  • 11.8.3 United Biotech Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 United Biotech Gefitinib Products Offered
  • 11.8.5 United Biotech Recent Development
• 11.9 Panacea Biotec
  • 11.9.1 Panacea Biotec Corporation Information
  • 11.9.2 Panacea Biotec Description, Business Overview and Total Revenue
  • 11.9.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Panacea Biotec Gefitinib Products Offered
  • 11.9.5 Panacea Biotec Recent Development
• 11.10 Cipla
  • 11.10.1 Cipla Corporation Information
  • 11.10.2 Cipla Description, Business Overview and Total Revenue
  • 11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Cipla Gefitinib Products Offered
  • 11.10.5 Cipla Recent Development
• 11.1 AstraZeneca
  • 11.1.1 AstraZeneca Corporation Information
  • 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
  • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 AstraZeneca Gefitinib Products Offered
  • 11.1.5 AstraZeneca Recent Development
• 11.12 Nobel Ilac Sanayii Ve Ticaret
  • 11.12.1 Nobel Ilac Sanayii Ve Ticaret Corporation Information
  • 11.12.2 Nobel Ilac Sanayii Ve Ticaret Description, Business Overview and Total Revenue
  • 11.12.3 Nobel Ilac Sanayii Ve Ticaret Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Nobel Ilac Sanayii Ve Ticaret Products Offered
  • 11.12.5 Nobel Ilac Sanayii Ve Ticaret Recent Development
• 11.13 Accure Labs
  • 11.13.1 Accure Labs Corporation Information
  • 11.13.2 Accure Labs Description, Business Overview and Total Revenue
  • 11.13.3 Accure Labs Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Accure Labs Products Offered
  • 11.13.5 Accure Labs Recent Development
• 11.14 Cadila Pharmaceuticals
  • 11.14.1 Cadila Pharmaceuticals Corporation Information
  • 11.14.2 Cadila Pharmaceuticals Description, Business Overview and Total Revenue
  • 11.14.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Cadila Pharmaceuticals Products Offered
  • 11.14.5 Cadila Pharmaceuticals Recent Development
• 11.15 Ethypharm
  • 11.15.1 Ethypharm Corporation Information
  • 11.15.2 Ethypharm Description, Business Overview and Total Revenue
  • 11.15.3 Ethypharm Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Ethypharm Products Offered
  • 11.15.5 Ethypharm Recent Development
• 11.16 Flagship Biotech International
  • 11.16.1 Flagship Biotech International Corporation Information
  • 11.16.2 Flagship Biotech International Description, Business Overview and Total Revenue
  • 11.16.3 Flagship Biotech International Sales, Revenue and Gross Margin (2015-2020)
  • 11.16.4 Flagship Biotech International Products Offered
  • 11.16.5 Flagship Biotech International Recent Development
• 11.17 Globela Pharma
  • 11.17.1 Globela Pharma Corporation Information
  • 11.17.2 Globela Pharma Description, Business Overview and Total Revenue
  • 11.17.3 Globela Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.17.4 Globela Pharma Products Offered
  • 11.17.5 Globela Pharma Recent Development
• 11.18 Jodas Expoim
  • 11.18.1 Jodas Expoim Corporation Information
  • 11.18.2 Jodas Expoim Description, Business Overview and Total Revenue
  • 11.18.3 Jodas Expoim Sales, Revenue and Gross Margin (2015-2020)
  • 11.18.4 Jodas Expoim Products Offered
  • 11.18.5 Jodas Expoim Recent Development
• 11.19 Nishchay Pharmaceuticals
  • 11.19.1 Nishchay Pharmaceuticals Corporation Information
  • 11.19.2 Nishchay Pharmaceuticals Description, Business Overview and Total Revenue
  • 11.19.3 Nishchay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.19.4 Nishchay Pharmaceuticals Products Offered
  • 11.19.5 Nishchay Pharmaceuticals Recent Development
• 11.20 Sichuan Xieli Pharmaceutical
  • 11.20.1 Sichuan Xieli Pharmaceutical Corporation Information
  • 11.20.2 Sichuan Xieli Pharmaceutical Description, Business Overview and Total Revenue
  • 11.20.3 Sichuan Xieli Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 11.20.4 Sichuan Xieli Pharmaceutical Products Offered
  • 11.20.5 Sichuan Xieli Pharmaceutical Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Gefitinib Market Estimates and Projections by Region
  • 12.1.1 Global Gefitinib Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Gefitinib Revenue Forecast by Regions 2021-2026
• 12.2 North America Gefitinib Market Size Forecast (2021-2026)
  • 12.2.1 North America: Gefitinib Sales Forecast (2021-2026)
  • 12.2.2 North America: Gefitinib Revenue Forecast (2021-2026)
  • 12.2.3 North America: Gefitinib Market Size Forecast by Country (2021-2026)
• 12.3 Europe Gefitinib Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Gefitinib Sales Forecast (2021-2026)
  • 12.3.2 Europe: Gefitinib Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Gefitinib Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Gefitinib Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Gefitinib Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Gefitinib Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Gefitinib Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Gefitinib Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Gefitinib Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Gefitinib Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Gefitinib Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Gefitinib Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Gefitinib Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Gefitinib Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Gefitinib Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Gefitinib Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Gefitinib Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source